Endocrine and Metabolic Disorders

Endocrine and metabolic diseases span a vast range of conditions. Together, they affect many millions of Americans and can profoundly decrease quality of life. NIDDK supports research on many of these conditions, including osteoporosis, cystic fibrosis, hypothyroidism, and obesity. Osteoporosis is a disease marked by reduced bone strength and linked to aging and fracture risk. 53 million people in the United States either have or are at risk for osteoporosis. Hypothyroidism, or underactive thyroid, affects about 4.6 percent of the U.S. population age 12 and older. More than 30,000 Americans have cystic fibrosis, an inherited disease in which salt and water cannot flow appropriately in many critical tissues. Despite dramatic advances in treatment and life expectancy, cystic fibrosis substantially reduces lifespan and its management is challenging.

      Related Conference of Endocrine and Metabolic Disorders

      May 19-20, 2025

      5th World Congress on Endocrine and Diabetes

      Rome, Italy
      May 19-20, 2025

      6th World Summit on Diabetes

      Rome, Italy
      June 04-05, 2025

      4th World Congress on Diabetes and Pediatric Endocrinology

      Edinburgh, Scotland
      July 29-30, 2025

      15th World Congress on Endocrinology and Diabetes

      Paris, France
      September 08-09, 2025

      3rd World congress and Expo on Diabetes

      Frankfurt, Germany
      October 30-31, 2025

      5th Annual Summit on Diabetes and Endocrinology

      Paris, France
      November 06-07, 2025

      8th Annual Meeting on Diabetes and Endocrinology

      Dubai, UAE
      November 20-21, 2025

      21st World Congress on Endocrinology & Diabetes

      Paris, France
      March 26-27, 2026

      7th Global summit on Diabetes and Endocrinology

      Amsterdam, Netherlands

      Endocrine and Metabolic Disorders Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in